Related Experiment Video
Updated: Jun 21, 2026
08:43
Calcification of Vascular Smooth Muscle Cells and Imaging of Aortic Calcification and Inflammation
Published on: May 31, 2016
Matrix metalloproteinases and peripheral arterial disease.
Chiara Busti1, Emanuela Falcinelli, Stefania Momi
1Division of Internal and Cardiovascular Medicine, Department of Internal Medicine, University of Perugia, Via E. dal Pozzo, 06126, Perugia, Italy.
Internal and Emergency Medicine
|July 24, 2009
Summary
Matrix metalloproteinases (MMPs) are key enzymes in atherothrombosis, influencing plaque development and rupture. Targeting MMPs offers a potential new treatment strategy for peripheral arterial disease (PAD).
Area of Science:
- Biochemistry
- Cardiovascular Biology
- Molecular Medicine
Background:
- Matrix metalloproteinases (MMPs) are enzymes degrading extracellular matrix.
- MMPs are implicated in atherothrombosis, including plaque formation, rupture, aneurysm, and critical limb ischemia.
- MMPs also regulate cellular functions like platelet and neutrophil activation, and vascular reactivity.
Purpose of the Study:
- To review the role of MMPs in atherothrombosis and peripheral arterial disease (PAD).
- To highlight MMPs as potential biomarkers for atherosclerosis and cardiovascular risk.
- To explore the therapeutic potential of targeting MMPs in PAD.
Main Methods:
- Literature review of studies on MMPs in atherothrombosis and PAD.
- Analysis of MMP involvement in atherosclerotic processes and PAD development.
- Examination of MMPs as biomarkers and therapeutic targets.
Main Results:
- MMPs are crucial in atherosclerotic plaque remodeling and PAD development.
- Elevated plasma levels of MMP-2 and MMP-9 correlate with PAD severity.
- Genetic variations in MMP genes are associated with PAD and critical limb ischemia risk.
Conclusions:
- MMPs play a significant role in the pathogenesis of PAD.
- MMP levels can serve as biomarkers for cardiovascular risk and PAD.
- Pharmacological inhibition of MMPs presents a promising therapeutic avenue for PAD treatment.
Related Concept Videos
01:30Peripheral Artery Disease I: Introduction
Peripheral artery disease (PAD) predominantly results from atherosclerosis, which involves the accumulation of fatty deposits, or plaques, within the walls of arteries. This causes them to narrow and harden, significantly reducing blood flow. PAD predominantly affects the legs, particularly the arteries supplying the thighs and calves. In rare cases, it may involve other arteries, including those in the arms.Etiology of PAD:The principal cause of PAD is atherosclerosis, which results from fatty...
01:23Role of Matrix Metalloproteases in Degradation of ECM
Matrix metalloproteases (MMPs) are enzymes involved in the hydrolysis of proteins and glycoproteins of the extracellular matrix. MMPs are essential for the migration and proliferation of cells through the dense matrix network, throughout embryonic development, and throughout morphogenesis. The first MMP activity discovered was a collagenase in a tadpole's tail undergoing metamorphosis. The active collagen deposition and modifications lead to the morphogenesis of tadpoles into the adult body.
A...
A...
01:27Peripheral Artery Disease III: Interprofessional Care
Peripheral Artery Disease (PAD) is characterized by narrowed arteries that diminish blood flow to the extremities. Effective management of PAD requires an interprofessional approach involving various healthcare professionals. The critical aspects of interprofessional care for PAD patients focus on risk factor modification, drug therapy, exercise therapy, nutrition therapy, critical limb ischemia care, and interventional radiology and surgical procedures.The primary treatment goal for PAD...
01:21Peripheral Arterial Disease II: Clinical Manifestations and Diagnostic Evaluation
Clinical manifestationsPeripheral Arterial Disease (PAD) manifests through a range of symptoms, from the characteristic intermittent claudication to atypical presentations and severe complications in advanced stages. Intermittent claudication, a hallmark symptom of PAD, presents as exercise-induced muscle pain that typically resolves within minutes of rest. This pain is reproducible and stems from inadequate blood flow, leading to the accumulation of lactic acid produced during anaerobic...
01:26Peripheral Artery Disease IV: Nursing Management
The nursing management of a patient with peripheral artery disease (PAD) begins with a thorough assessment of the patient’s health history and clinical manifestations.AssessmentHealth History: Evaluate the patient’s history of hypertension, hyperlipidemia, family history of cardiovascular issues, and lifestyle factors such as dietary patterns, smoking, and physical activity.Physical Examination:Assess the affected extremity for decreased or absent peripheral pulses, temperature changes,...
01:30Atherosclerosis I: Introduction
Atherosclerosis is a progressive disorder characterized by the buildup of plaques on the arterial inner wall, causing them to narrow and harden over time. These plaques comprise lipids, calcium, blood components, carbohydrates, and fibrous tissue. The process primarily affects the intima of large and medium-sized arteries, reducing blood flow in any artery.Etiology and risk factorsThe cause of atherosclerosis is multifactorial, involving a complex interplay among endothelial injury, lipid...